Medigen Vaccine Biologics Corp (高端疫苗) yesterday reported higher neutralizing antibody levels in people who were given its COVID-19 vaccine as a booster after two AstraZeneca doses, the company said.
In a trial of 200 participants who received Medigen’s COVID-19 vaccine, neutralizing antibodies against the Omicron variant of SARS-CoV-2 grew by 5.7 times one month after being administered, Taoyuan General Hospital said.
Medigen said that the results have been submitted to medRxiv, an online platform for researchers to share complete but unpublished papers.
Photo: Chu Pei-hsiung, Taipei Times
Another trial conducted by National Taiwan University Hospital showed that among 45 participants who received three doses of the Medigen vaccine, the level of neutralizing antibodies against the Omicron variant gradually fell, similar to those who received three doses of mRNA COVID-19 vaccines such as those made by Pfizer-BionNTech and Moderna Inc.
“This result indicates that our vaccine, as a booster shot, provided protection against the Omicron variant to some degree,” Medigen said.
The company said that people who have received adenovirus-based vaccines, such as the one made by AstraZeneca, or mRNA-based vaccines could consider taking the Medigen vaccine as a third shot given its safety profile, mild side effects and immunogenicity.
Medigen’s vaccine is a protein subunit vaccine, developed by recombinant technology. It comprises the recombinant spike protein of SARS-CoV-2 as the antigen to help a person’s body recognize the virus if a person becomes infected.
The company said that it would recruit 960 participants for a “mix-and-match” clinical trial in which it plans to test the safety and immunogenicity of different combinations of multiple brands of COVID-19 vaccines.
Medigen has received a subsidy of US$2.3 million from the Coalition for Epidemic Preparedness Innovations, an international foundation, to conduct the trial.
The trial is to be carried out in four hospitals, and recruitment of participants has begun, it said.
As of Sunday, 1.51 million people had received two doses of Medigen’s vaccine, accounting for four percent of 36.17 million who had received two COVID-19 shots, while 112,838 people had chosen the vaccine as booster shot, Centers for Disease Control data showed.
Merida Industry Co (美利達) has seen signs of recovery in the US and European markets this year, as customers are gradually depleting their inventories, the bicycle maker told shareholders yesterday. Given robust growth in new orders at its Taiwanese factory, coupled with its subsidiaries’ improving performance, Merida said it remains confident about the bicycle market’s prospects and expects steady growth in its core business this year. CAUTION ON CHINA However, the company must handle the Chinese market with great caution, as sales of road bikes there have declined significantly, affecting its revenue and profitability, Merida said in a statement, adding that it would
i Gasoline and diesel prices at fuel stations are this week to rise NT$0.1 per liter, as tensions in the Middle East pushed crude oil prices higher last week, CPC Corp, Taiwan (台灣中油) and Formosa Petrochemical Corp (台塑石化) said yesterday. International crude oil prices last week rose for the third consecutive week due to an escalating conflict between Israel and Iran, as the market is concerned that the situation in the Middle East might affect crude oil supply, CPC and Formosa said in separate statements. Front-month Brent crude oil futures — the international oil benchmark — rose 3.75 percent to settle at US$77.01
RISING: Strong exports, and life insurance companies’ efforts to manage currency risks indicates the NT dollar would eventually pass the 29 level, an expert said The New Taiwan dollar yesterday rallied to its strongest in three years amid inflows to the nation’s stock market and broad-based weakness in the US dollar. Exporter sales of the US currency and a repatriation of funds from local asset managers also played a role, said two traders, who asked not to be identified as they were not authorized to speak publicly. State-owned banks were seen buying the greenback yesterday, but only at a moderate scale, the traders said. The local currency gained 0.77 percent, outperforming almost all of its Asian peers, to close at NT$29.165 per US dollar in Taipei trading yesterday. The
RECORD LOW: Global firms’ increased inventories, tariff disputes not yet impacting Taiwan and new graduates not yet entering the market contributed to the decrease Taiwan’s unemployment rate last month dropped to 3.3 percent, the lowest for the month in 25 years, as strong exports and resilient domestic demand boosted hiring across various sectors, the Directorate-General of Budget, Accounting and Statistics (DGBAS) said yesterday. After seasonal adjustments, the jobless rate eased to 3.34 percent, the best performance in 24 years, suggesting a stable labor market, although a mild increase is expected with the graduation season from this month through August, the statistics agency said. “Potential shocks from tariff disputes between the US and China have yet to affect Taiwan’s job market,” Census Department Deputy Director Tan Wen-ling
RSS